Search for partners for the IMI2 topic on diabetic cardiomyopathy

Cardiolinc members are looking for partners to build a consortium for an application for the future call of IMI2 on the topic “Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches”.

If you are interested in participating, please contact us!

Here are some of the collaborative projects within the network


COST Action preparation

Cardiolinc coordinator Yvan Devaux and his team from the Luxembourg Institute of Health prepared a COST Action aiming to advance research on the role of RNAs in cardiovascular disease. Even if you are not a Cardiolinc member, you can get involved. If you are interested in participating, please contact us and we will be happy to provide you with additional details and aims of the different working groups.



Cardiolinc members FiralisHannover Medical School and Luxembourg Institute of Health, together with the LifeSequencing company, secured funding through the Eurostars program for a 3-year project aiming at developing an in vitro diagnostic assay for prognostication of patients with acute myocardial infarction.



Cardiolinc members from Firalis and the Luxembourg Institute of Health collaborate to develop a novel early stage prognostic test for clinical outcome in acute myocardial infarction patients.